Contract analysis

I. Introduction and Purpose On January 13, 2023, Hargrove-Dalton Defense Systems, Inc. ("HDDS") filed its Answer and Counterclaim in the above-captioned declaratory judgment action pending before the Honorable Richard M. Brannigan, United States District Judge, in the United States District Court for the Southern District of New York. HDDS is represented by Leonard Trager (lead partner) and Megan Forsythe (senior ass

II. Procedural Background WAL filed its Verified Complaint for Declaratory Judgment on November 28, 2022, asserting a single count under the Declaratory Judgment Act, 28 U.S.C. §§ 2201–2202. The Complaint was verified by Marcus Whitmore, President and Chief Executive Officer of WAL, and is supported by exhibits including the Teaming Agreement, the DCMA Contracting Officer's Preliminary Determination ("COPD"), the Sep

1. First Declaration: That Section 11.4 of the Teaming Agreement dated June 12, 2019, between HDDS and WAL, does not obligate WAL to indemnify HDDS for the cost overruns identified in the COPD dated August 1, 2022, issued by Administrative Contracting Officer Lt. Col. Sandra M. Vickers of the Defense Contract Management Agency ("DCMA");

2. Second Declaration: That even if Section 11.4 applies, WAL's indemnification obligation extends only to overruns "caused by" WAL's acts or omissions, and that the cost overruns at issue were caused by HDDS and/or force-majeure events beyond WAL's control; and

3. Third Declaration: That HDDS's indemnification demand of $14,726,583 is overbroad because it includes $1,909,142 in cost overruns attributable to non-Work-Package-4 activities for which WAL bears no contractual responsibility. The case was assigned to Judge Brannigan upon filing and referred to Magistrate Judge the Honorable Allison P. Kurtz for pretrial matters. HDDS was served on December 23, 2022, through its r

III. Summary of HDDS's Answer HDDS's Answer tracks each numbered paragraph of WAL's Complaint. Below is a summary of the material admissions, denials, and affirmative defenses, along with our preliminary analysis. A. Admissions HDDS makes several important admissions that narrow the range of contested issues in the case: Jurisdiction and Venue. HDDS admits that this Court has subject-matter jurisdiction under 28 U.S.

1. Failure to State a Claim / No Justiciable Controversy (First Affirmative Defense) HDDS argues that WAL's declaratory judgment action is premature because the DCMA administrative review is ongoing and no Contracting Officer's Final Decision ("COFD") has been issued. HDDS contends that no actual controversy exists under 28 U.S.C. § 2201 until costs are formally disallowed through a COFD, and that the COPD — as a pre

2. Waiver / Estoppel (Second Affirmative Defense) HDDS contends that WAL waived its right to contest indemnification by (a) failing to timely object to the COPD cost allocation and (b) continuing performance under the Teaming Agreement after the COPD was issued on August 1, 2022. Analysis: This defense is weak on the facts and the law. WAL is a subcontractor and has no privity of contract with the United States Gover

3. Unclean Hands (Third Affirmative Defense) HDDS alleges that WAL's own performance failures caused the cost overruns, including non-conforming machining tolerances leading to $5.1 million in rework, and that WAL cannot seek equitable relief while responsible for the underlying harm. Analysis: This affirmative defense is essentially a merits argument repackaged as a traditional equitable defense. HDDS is asserting t

4. Failure to Mitigate (Fourth Affirmative Defense) HDDS asserts that WAL failed to take reasonable steps to mitigate cost overruns, including: (a) failing to secure alternative titanium supply sources when raw-material prices escalated (the $4.2 million titanium price component), and (b) failing to implement corrective machining processes in a timely manner (relating to the $5.1 million rework component). Analysis:

5. Contractual Indemnification Obligation Bars Declaratory Relief (Fifth Affirmative Defense) HDDS argues that WAL's indemnification obligation under Section 11.4 is clear and unambiguous and that declaratory relief is inappropriate where the contract's plain language resolves the dispute without need for judicial construction. Analysis: This is a merits defense dressed as a jurisdictional or procedural objection. HD

IV. Analysis of HDDS's Counterclaim A. Overview of the Counterclaim HDDS asserts a single counterclaim for contractual indemnification under Section 11.4 of the Teaming Agreement. The counterclaim is styled as "Count I — Breach of Contract: Contractual Indemnification" and seeks the following relief: (a) A judgment against WAL in the amount of $14,726,583, representing the full amount of the cost overruns identified

1. Triggering of Section 11.4(b) HDDS alleges that the DCMA COPD constitutes a "claim by the U.S. Government that costs incurred under Team Member's Work Package are unallowable, unreasonable, or otherwise subject to disallowance" within the meaning of Section 11.4(b). HDDS characterizes the COPD as a formal government action that identifies specific costs as subject to disallowance and that satisfies the triggering

2. Causation — The Four Components HDDS alleges that all cost overruns were caused by WAL's acts or omissions in performing Work Package 4. The counterclaim identifies four specific cost-overrun components, which collectively account for $12,800,000 of the $14,726,583 total. (The remaining $1,926,583 is not individually itemized in the counterclaim.) Each component and WAL's anticipated response are discussed below.

3. Full Amount of COPD — Inclusion of Non-WP-4 Overruns ($1,909,142) HDDS demands $14,726,583 — the full COPD amount — not merely the $12,817,441 (87.03%) that the COPD attributed to Work Package 4. HDDS alleges that the remaining $1,909,142 (12.97%), which the COPD attributes to other work packages, is also attributable to cascading effects of WAL's WP-4 performance failures. Specifically, HDDS contends that WAL's s

4. Attorneys' Fees Under Section 11.6 HDDS claims entitlement to attorneys' fees and litigation costs as the prevailing party under Section 11.6 of the Teaming Agreement. Analysis: Section 11.6 is a bilateral fee-shifting provision — it entitles the "prevailing party" in any indemnification dispute to recover reasonable attorneys' fees and costs. This means that if WAL prevails on its declaratory judgment claim and d

V. Evaluation of WAL's Defenses to the Counterclaim WAL has multiple defenses available to it in responding to HDDS's counterclaim. The principal defenses are discussed below. A. Causation Defense (Section 11.4(b) — "caused by Team Member's acts or omissions") The causation defense is WAL's core defense and the central issue in the case. Section 11.4(b) limits WAL's indemnification obligation to claims "to the extent

Section 18.1 of the Teaming Agreement provides that the agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to principles of conflicts of law. This choice-of-law provision is enforceable and will govern the interpretation of the indemnification provisions at issue. New York law provides WAL with an important interpretive advantage. New York courts construe

VI. Recommended Strategy for Reply to Counterclaim A. Timing WAL's Reply to the Counterclaim is due February 3, 2023, which is twenty-one days from the date of service of the Answer and Counterclaim on January 13, 2023, pursuant to Federal Rule of Civil Procedure 12(a)(1)(B). We do not anticipate requesting an extension of time; the issues are sufficiently well-defined to permit preparation of the Reply within the al

1. Deny Material Allegations. The Reply should deny each material allegation in the counterclaim, including: • Deny that WAL caused the cost overruns identified in the COPD; • Deny that the full $14,726,583 is attributable to WAL's performance of WP-4; • Deny that Section 11.4(b) has been triggered by the COPD, which is a preliminary determination and not a formal "claim" within the meaning of the Teaming Agreement;

2. Assert Affirmative Defenses. The Reply should assert the following affirmative defenses to the counterclaim: (a) Failure to Satisfy the Causation Requirement of Section 11.4(b). WAL's indemnification obligation, if any, extends only to cost overruns "caused by" WAL's own acts or omissions. The cost overruns at issue were caused by HDDS's conduct — including specification deficiencies, mid-stream specification chan

3. Preserve Right to Seek Attorneys' Fees. The Reply should expressly preserve WAL's right to seek attorneys' fees and litigation costs under Section 11.6 of the Teaming Agreement in the event that WAL is the prevailing party in this action. Section 11.6 is a bilateral provision, and WAL's potential entitlement to fee recovery should be asserted early and preserved throughout the proceedings.

4. Do Not Assert a Counterclaim at This Stage. At this time, we do not recommend that WAL assert an affirmative counterclaim against HDDS for breach of the Teaming Agreement. WAL's Verified Complaint for Declaratory Judgment already seeks the relief that WAL needs — a declaration that it is not obligated to indemnify HDDS. Asserting an affirmative breach-of-contract counterclaim against HDDS at this stage could compl

VII. Coordination Items A. Ashford & Reeves LLP WAL is represented by Harold Reeves and Natalie Cheng of Ashford & Reeves LLP in connection with the DCMA administrative review and COFD process. Their work is complementary to our litigation efforts but involves a separate engagement focused on government-contract regulatory matters. We should coordinate with Ashford & Reeves on the following items: • DCMA Administrati

VIII. Recommended Next Steps and Timeline The following table summarizes the key action items, responsible persons, and target dates:

IX. Conclusion HDDS's Answer and Counterclaim are largely as anticipated in our Preliminary Case Assessment Memorandum dated November 7, 2022. The Answer contains no major surprises, and the affirmative defenses range from weak (ripeness/justiciable controversy and waiver/estoppel) to moderately concerning (failure to mitigate). The counterclaim seeks $14,726,583 in contractual indemnification plus attorneys' fees un